Alterity Therapeutics (ATHE) Net Cash Flow (2010 - 2020)

Alterity Therapeutics' Net Cash Flow history runs 7 years deep, the most recent figure standing at -$6.2 million for Q2 2020.

• In Q2 2020, Net Cash Flow rose 36.76% year-over-year to -$6.2 million; the TTM figure through Dec 2021 stood at -$6.2 million (up 64.8% YoY), while the FY2025 annual figure was $13.3 million, up 692.99% from the prior year.
• Net Cash Flow was -$6.2 million for Q2 2020 at Alterity Therapeutics, down from -$1.6 million in the prior quarter.
• In the past five years, Net Cash Flow ranged from a high of -$47278.4 in Q2 2018 to a low of -$9.8 million in Q2 2019.
• Historically, Net Cash Flow has averaged -$3.8 million across 5 years, with a median of -$4.4 million in 2017.
• The sharpest annual moves came in 2018 and 2019: Net Cash Flow jumped 98.93% in 2018, then plunged 20575.33% in 2019.
• A 5-year view of Net Cash Flow shows it stood at -$598231.8 in 2016, then plunged by 56.04% to -$933486.7 in 2017, then tumbled by 444.27% to -$5.1 million in 2018, then jumped by 68.41% to -$1.6 million in 2019, then slumped by 285.17% to -$6.2 million in 2020.
• The last three Net Cash Flow figures came in at -$6.2 million (Q2 2020), -$1.6 million (Q4 2019), and -$9.8 million (Q2 2019), per Business Quant data.